Repros (RPRX) Enters $11.1M Direct Placement

Repros Therapeutics Inc. (Nasdaq: RPRX) today announced that it has entered into definitive agreements with certain institutional investors, including certain existing shareholders, to sell an aggregate of 2,463,538 shares of common stock, par value $0.001 per share ("Common Stock") in a registered direct offering for gross proceeds of approximately $11.1 million, before deducting placement agent's fees and estimated offering expenses. The investors have agreed to purchase the shares of Common Stock for a price of $4.50 per share.

---

Get immediate access to market moving news and alerts with StreetInsider.com Premium - FREE TRIAL!

You May Also Be Interested In

• Euroseas (ESEA) commences 13.9M rights offering
• Yahoo!'s (YHOO) New Browser Seeks to Challenge Google (GOOG), Gain Apple (AAPL) Users; Glitches Abound
• BofA (BAC), Barclays (BCS) to Sell Remaining Archstone Interest in $1.58B Deal to Lehman Bros.

Create E-mail Alert Related Categories

Corporate News, Equity Offerings

Add Your Comment

Name

Subject

Body

Verification can't see the text?
click here to refresh the image.
what's this?

Follow StreetInsider.com On Twitter